We are live on ! Find out more
SP

Syncona Portfolio Portfolio holdings

AUM $25.7M
1-Year Est. Return 13.32%
This Fund
S&P 500
This Quarter Est. Return
-33.73%
1 Year Est. Return
+13.32%
3 Year Est. Return
+8.47%
5 Year Est. Return
10 Year Est. Return
AUM
$105M
AUM Growth
$0
Cap. Flow
+$23.6M
Cap. Flow %
22.51%
Top 10 Hldgs %
100%
Holding
4
New
Increased
1
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACHL
1
DELISTED
Achilles Therapeutics
ACHL
$55.5M 53.06%
11,086,909
AUTL
2
Autolus Therapeutics
AUTL
$386M
$38.1M 36.42%
7,346,829
FRLN
3
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$5.84M 5.58%
1,466,508
+1,269,841
+646% +$23.6M
ADAP
4
DELISTED
Adaptimmune Therapeutics
ADAP
$5.17M 4.93%
1,377,294

Similar funds

Syncona Portfolio's Q1 2022 Portfolio in Review

As of Q1 2022, Syncona Portfolio held 4 positions worth $105M, unchanged from the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Syncona Portfolio deployed $23.6M of net new capital in Q1 2022, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Syncona Portfolio added most to Freeline Therapeutics Holdings plc American Depositary Shares in Q1 2022, an estimated $23.6M increase.
  • Syncona Portfolio's ten largest holdings make up 100% of its $105M portfolio in Q1 2022.
  • Syncona Portfolio opened 0 new positions and closed 0 in Q1 2022.
  • Syncona Portfolio's portfolio value was unchanged quarter-over-quarter at $105M.

Based on Syncona Portfolio's 13F filing for Q1 2022, filed 31 May 2022.